https://www.zonebourse.com/cours/action/HALOZYME-THERAPEUTICS-INC-50245/actualite/Halozyme-annonce-que-Takeda-a-recu-l-approbation-de-la-FDA-pour-Hyqvia-coformule-avec-Enhanze--45752248/?utm_source=telegram&utm_medium=social&utm_campaign=share